TreeWAS – Variant ID: rs808225

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.911	0.089
K25 Gastric ulcer	0.000	0.931	0.069
K25.3 Acute without haemorrhage or perforation	0.000	0.936	0.064
K25.7 Chronic without haemorrhage or perforation	0.000	0.942	0.058
K25.0 Acute with haemorrhage	0.000	0.948	0.052
K25.5 Chronic or unspecified with perforation	0.000	0.950	0.050
K25.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.950	0.049
K25.2 Acute with both haemorrhage and perforation	0.000	0.950	0.049
K25.1 Acute with perforation	0.000	0.950	0.049
K25.4 Chronic or unspecified with haemorrhage	0.000	0.965	0.035
C62.9 Testis, unspecified	0.000	0.979	0.021
L81.4 Other melanin hyperpigmentation	0.000	0.987	0.013
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.987	0.013
I61 Intracerebral haemorrhage	0.000	0.988	0.012
N72 Inflammatory disease of cervix uteri	0.011	0.989	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.989	0.011
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.989	0.011
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.989	0.011
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.989	0.011
C62 Malignant neoplasm of testis	0.000	0.990	0.010
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.990	0.010
I61.8 Other intracerebral haemorrhage	0.000	0.990	0.010
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.990	0.010
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.991	0.009
T42.4 Benzodiazepines	0.000	0.991	0.009
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.992	0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.992	0.008
T42.1 Iminostilbenes	0.000	0.992	0.008
T42.0 Hydantoin derivatives	0.000	0.992	0.008
C62.1 Descended testis	0.000	0.992	0.008
C62.0 Undescended testis	0.000	0.992	0.008
O72.0 Third-stage haemorrhage	0.008	0.992	0.000
T78.3 Angioneurotic oedema	0.000	0.992	0.008
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.993	0.007
Z83.5 Family history of eye and ear disorders	0.007	0.993	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.993	0.007
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.993	0.007
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.993	0.007
T42.3 Barbiturates	0.000	0.993	0.007
T42.2 Succinimides and oxazolidinediones	0.000	0.993	0.007
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.993	0.007
N35.9 Urethral stricture, unspecified	0.000	0.993	0.007
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.993	0.007
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.993	0.007
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.994	0.006
H59.0 Vitreous syndrome following cataract surgery	0.000	0.994	0.006
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.994	0.005
M79.0 Rheumatism, unspecified	0.000	0.995	0.005
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.995	0.005
H57 Other disorders of eye and adnexa	0.000	0.995	0.005
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.995	0.005
H55-H59 Other disorders of eye and adnexa	0.000	0.995	0.005
H57.9 Disorder of eye and adnexa, unspecified	0.000	0.995	0.005
S92.30 Fracture of metatarsal bone (closed)	0.005	0.995	0.000
H57.1 Ocular pain	0.000	0.996	0.004
H57.0 Anomalies of pupillary function	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.000	0.996	0.004
N35 Urethral stricture	0.000	0.996	0.004
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.996	0.004
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.996	0.004
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
M79.04 Rheumatism, unspecified (Hand)	0.000	0.996	0.004
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.996	0.004
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.996	0.004
N35.8 Other urethral stricture	0.000	0.996	0.004
C78.2 Secondary malignant neoplasm of pleura	0.000	0.996	0.004
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.996	0.004
M79.08 Rheumatism, unspecified (Other)	0.000	0.996	0.004
F01.9 Vascular dementia, unspecified	0.000	0.996	0.004
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.996	0.004
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.996	0.004
H55 Nystagmus and other irregular eye movements	0.000	0.996	0.004
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.996	0.003
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.996	0.004
M25.76 Osteophyte (Lower leg)	0.000	0.996	0.004
C80.9 Malignant neoplasm, unspecified	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.996	0.004
H57.8 Other specified disorders of eye and adnexa	0.000	0.996	0.004
C71.3 Parietal lobe	0.003	0.996	0.000
C80 Malignant neoplasm without specification of site	0.000	0.997	0.003
C71 Malignant neoplasm of brain	0.003	0.997	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.000	0.997	0.003
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.003
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.000	0.997	0.003
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.997	0.003
N35.0 Posttraumatic urethral stricture	0.000	0.997	0.003
C71.9 Brain, unspecified	0.003	0.997	0.000
L81 Other disorders of pigmentation	0.000	0.997	0.003
C71.7 Brain stem	0.003	0.997	0.000
C71.4 Occipital lobe	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
E27.2 Addisonian crisis	0.000	0.997	0.003
E27 Other disorders of adrenal gland	0.000	0.997	0.003
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
M05.9 Seropositive rheumatoid arthritis, unspecified	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.003
E27.1 Primary adrenocortical insufficiency	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
H35.9 Retinal disorder, unspecified	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.000	0.997	0.003
C71.6 Cerebellum	0.003	0.997	0.000
R94.3 Abnormal results of cardiovascular function studies	0.003	0.997	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.997	0.003
L81.2 Freckles	0.000	0.997	0.003
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
C71.0 Cerebrum, except lobes and ventricles	0.003	0.997	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.997	0.003
F80.1 Expressive language disorder	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
E21.3 Hyperparathyroidism, unspecified	0.000	0.997	0.003
C71.2 Temporal lobe	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
C71.5 Cerebral ventricle	0.003	0.997	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.000	0.997	0.003
H58.1 Visual disturbances in diseases classified elsewhere	0.000	0.997	0.003
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.000	0.997	0.003
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.000	0.997	0.003
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.003
L81.7 Pigmented purpuric dermatosis	0.000	0.997	0.003
L81.6 Other disorders of diminished melanin formation	0.000	0.997	0.003
L81.5 Leukoderma, not elsewhere classified	0.000	0.997	0.003
L81.3 Cafe au lait spots	0.000	0.997	0.003
L81.1 Chloasma	0.000	0.997	0.003
S92.3 Fracture of metatarsal bone	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
O36.5 Maternal care for poor foetal growth	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.002
E27.5 Adrenomedullary hyperfunction	0.000	0.997	0.002
E27.0 Other adrenocortical overactivity	0.000	0.997	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
L81.8 Other specified disorders of pigmentation	0.000	0.997	0.002
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.997	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.002
C60-C63 Malignant neoplasms of male genital organs	0.000	0.997	0.002
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.000	0.998	0.002
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
C60 Malignant neoplasm of penis	0.000	0.998	0.002
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.000	0.998	0.002
L81.0 Postinflammatory hyperpigmentation	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
D37.4 Colon	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
C60.9 Penis, unspecified	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.002
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
S92.31 Fracture of metatarsal bone (open)	0.002	0.998	0.000
C76.0 Head, face and neck	0.000	0.998	0.002
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
C60.0 Prepuce	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
F01 Vascular dementia	0.000	0.998	0.002
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.998	0.002
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
C60.1 Glans penis	0.000	0.998	0.002
C76.2 Abdomen	0.000	0.998	0.002
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.002	0.998	0.000
T47.4 Other laxatives	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
M71.38 Other bursal cyst (Other)	0.002	0.998	0.000
C60.8 Overlapping lesion of penis	0.000	0.998	0.002
C60.2 Body of penis	0.000	0.998	0.002
E24.9 Cushing's syndrome, unspecified	0.000	0.998	0.002
I05.9 Mitral valve disease, unspecified	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
M89.8 Other specified disorders of bone	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
R09.3 Abnormal sputum	0.000	0.998	0.002
T93.0 Sequelae of open wound of lower limb	0.000	0.998	0.002
M88.9 Paget's disease of bone, unspecified	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.998	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.000	0.998	0.002
G44.8 Other specified headache syndromes	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.998	0.002
M89.0 Algoneurodystrophy	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.998	0.001
F01.1 Multi-infarct dementia	0.000	0.998	0.002
I82.8 Embolism and thrombosis of other specified veins	0.000	0.998	0.002
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.998	0.002
C76.7 Other ill-defined sites	0.000	0.998	0.002
C76.5 Lower limb	0.000	0.998	0.002
C76.4 Upper limb	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.000	0.998	0.002
F01.8 Other vascular dementia	0.000	0.998	0.002
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.998	0.002
F01.2 Subcortical vascular dementia	0.000	0.998	0.002
F01.0 Vascular dementia of acute onset	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.001
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T78.2 Anaphylactic shock, unspecified	0.000	0.998	0.002
E24 Cushing's syndrome	0.000	0.998	0.002
M71.34 Other bursal cyst (Hand)	0.002	0.998	0.000
C76.1 Thorax	0.000	0.998	0.002
G44.2 Tension-type headache	0.000	0.998	0.002
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.002	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.002	0.998	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.002	0.998	0.000
M71.3 Other bursal cyst	0.002	0.998	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.000	0.998	0.001
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.000	0.998	0.001
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.000	0.998	0.001
M88.94 Paget's disease of bone, unspecified (Hand)	0.000	0.998	0.001
M88.93 Paget's disease of bone, unspecified (Forearm)	0.000	0.998	0.001
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.000	0.998	0.001
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.000	0.998	0.001
S92.10 Fracture of talus (closed)	0.002	0.998	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
C63.9 Male genital organ, unspecified	0.000	0.998	0.001
C63.8 Overlapping lesion of male genital organs	0.000	0.998	0.001
C63.7 Other specified male genital organs	0.000	0.998	0.001
C63.1 Spermatic cord	0.000	0.998	0.001
C63.0 Epididymis	0.000	0.998	0.001
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.001	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.002	0.998	0.000
A63.0 Anogenital (venereal) warts	0.000	0.998	0.002
J17.1 Pneumonia in viral diseases classified elsewhere	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.001
M48.04 Spinal stenosis (Thoracic region)	0.002	0.998	0.000
M71.37 Other bursal cyst (Ankle and foot)	0.002	0.998	0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.000	0.998	0.001
K38.1 Appendicular concretions	0.000	0.998	0.002
M89.08 Algoneurodystrophy (Other)	0.001	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.001	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.001	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.001	0.998	0.000
L81.9 Disorder of pigmentation, unspecified	0.000	0.998	0.002
Y54.4 Loop [high-ceiling] diuretics	0.000	0.998	0.002
M77.02 Medial epicondylitis (Upper arm)	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.998	0.001
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.998	0.002
O28.1 Abnormal biochemical finding on antenatal screening of mother	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.002
M89 Other disorders of bone	0.002	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.001	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.000	0.998	0.001
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.002
F80 Specific developmental disorders of speech and language	0.000	0.998	0.001
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.000	0.998	0.001
M89.09 Algoneurodystrophy (Site unspecified)	0.001	0.998	0.000
R25.2 Cramp and spasm	0.000	0.998	0.002
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.000	0.998	0.001
C63.2 Scrotum	0.000	0.998	0.001
C76.3 Pelvis	0.000	0.998	0.001
E24.8 Other Cushing's syndrome	0.000	0.998	0.001
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.998	0.001
E24.3 Ectopic ACTH syndrome	0.000	0.998	0.001
E24.1 Nelson's syndrome	0.000	0.998	0.001
H81.0 Meniere's disease	0.000	0.998	0.002
L03.3 Cellulitis of trunk	0.000	0.998	0.002
M89.5 Osteolysis	0.001	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.001	0.998	0.000
T78.9 Adverse effect, unspecified	0.000	0.998	0.001
T93.8 Sequelae of other specified injuries of lower limb	0.001	0.998	0.000
F03 Unspecified dementia	0.000	0.998	0.002
E20-E35 Disorders of other endocrine glands	0.000	0.998	0.002
M71.39 Other bursal cyst (Site unspecified)	0.001	0.998	0.000
M71.36 Other bursal cyst (Lower leg)	0.001	0.998	0.000
M71.35 Other bursal cyst (Pelvic region and thigh)	0.001	0.998	0.000
M71.33 Other bursal cyst (Forearm)	0.001	0.998	0.000
M71.32 Other bursal cyst (Upper arm)	0.001	0.998	0.000
M71.31 Other bursal cyst (Shoulder region)	0.001	0.998	0.000
M71.30 Other bursal cyst (Multiple sites)	0.001	0.998	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.998	0.002
D04.4 Skin of scalp and neck	0.000	0.998	0.001
T83.3 Mechanical complication of intra-uterine contraceptive device	0.000	0.998	0.001
M89.55 Osteolysis (Pelvic region and thigh)	0.001	0.999	0.000
E24.0 Pituitary-dependent Cushing's disease	0.000	0.999	0.001
T78.8 Other adverse effects, not elsewhere classified	0.000	0.999	0.001
G44 Other headache syndromes	0.000	0.999	0.001
M89.4 Other hypertrophic osteo-arthropathy	0.001	0.999	0.000
M90.10 Periostitis in other infectious diseases classified elsewhere (Multiple sites)	0.001	0.999	0.000
S82.20 Fracture of shaft of tibia (closed)	0.000	0.999	0.001
E21.4 Other specified disorders of parathyroid gland	0.000	0.999	0.001
K43.0 Ventral hernia with obstruction, without gangrene	0.001	0.999	0.000
K62.3 Rectal prolapse	0.001	0.999	0.000
E14.5 With peripheral circulatory complications	0.001	0.999	0.000
K38.8 Other specified diseases of appendix	0.000	0.999	0.001
N36.3 Prolapsed urethral mucosa	0.000	0.999	0.001
E21.2 Other hyperparathyroidism	0.000	0.999	0.001
E34.8 Other specified endocrine disorders	0.000	0.999	0.001
G44.3 Chronic posttraumatic headache	0.000	0.999	0.001
M89.6 Osteopathy after poliomyelitis	0.001	0.999	0.000
M89.2 Other disorders of bone development and growth	0.001	0.999	0.000
M89.1 Epiphyseal arrest	0.001	0.999	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.999	0.001
M48.02 Spinal stenosis (Cervical region)	0.001	0.999	0.000
M89.38 Hypertrophy of bone (Other)	0.001	0.999	0.000
G04.0 Acute disseminated encephalitis	0.001	0.999	0.000
M89.3 Hypertrophy of bone	0.001	0.999	0.000
S92.1 Fracture of talus	0.001	0.999	0.000
J17 Pneumonia in diseases classified elsewhere	0.001	0.999	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.999	0.001
F80.9 Developmental disorder of speech and language, unspecified	0.000	0.999	0.001
F80.8 Other developmental disorders of speech and language	0.000	0.999	0.001
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.000	0.999	0.001
F80.2 Receptive language disorder	0.000	0.999	0.001
F80.0 Specific speech articulation disorder	0.000	0.999	0.001
T40.4 Other synthetic narcotics	0.000	0.999	0.001
G04 Encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.999	0.001
M79.79 Fibromyalgia (Site unspecified)	0.000	0.999	0.001
M89.06 Algoneurodystrophy (Lower leg)	0.001	0.999	0.000
M89.59 Osteolysis (Site unspecified)	0.001	0.999	0.000
M89.58 Osteolysis (Other)	0.001	0.999	0.000
M89.57 Osteolysis (Ankle and foot)	0.001	0.999	0.000
M89.56 Osteolysis (Lower leg)	0.001	0.999	0.000
M89.54 Osteolysis (Hand)	0.001	0.999	0.000
M89.53 Osteolysis (Forearm)	0.001	0.999	0.000
M89.52 Osteolysis (Upper arm)	0.001	0.999	0.000
M89.51 Osteolysis (Shoulder region)	0.001	0.999	0.000
M89.50 Osteolysis (Multiple sites)	0.001	0.999	0.000
E34 Other endocrine disorders	0.000	0.999	0.001
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.001	0.999	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.999	0.001
E32 Diseases of thymus	0.000	0.999	0.001
E30 Disorders of puberty, not elsewhere classified	0.000	0.999	0.001
M05 Seropositive rheumatoid arthritis	0.000	0.999	0.001
G44.1 Vascular headache, not elsewhere classified	0.000	0.999	0.001
Z43.1 Attention to gastrostomy	0.000	0.999	0.001
E31 Polyglandular dysfunction	0.000	0.999	0.001
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.001	0.999	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.001	0.999	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.001	0.999	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.001	0.999	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.001	0.999	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.001	0.999	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.001	0.999	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.001	0.999	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.001	0.999	0.000
K38.9 Disease of appendix, unspecified	0.000	0.999	0.001
X59.2 School, other institution and public administrative area	0.000	0.999	0.001
E26 Hyperaldosteronism	0.000	0.999	0.001
E29 Testicular dysfunction	0.000	0.999	0.001
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.000	0.999	0.001
M89.19 Epiphyseal arrest (Site unspecified)	0.001	0.999	0.000
M89.18 Epiphyseal arrest (Other)	0.001	0.999	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.001	0.999	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.001	0.999	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.001	0.999	0.000
M89.14 Epiphyseal arrest (Hand)	0.001	0.999	0.000
M89.13 Epiphyseal arrest (Forearm)	0.001	0.999	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.001	0.999	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.001	0.999	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.001	0.999	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.001	0.999	0.000
M89.28 Other disorders of bone development and growth (Other)	0.001	0.999	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.001	0.999	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.001	0.999	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.001	0.999	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.001	0.999	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.001	0.999	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.001	0.999	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.001	0.999	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.001	0.999	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.001	0.999	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.001	0.999	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.001	0.999	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.001	0.999	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.001	0.999	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.001	0.999	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.001	0.999	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.001	0.999	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.001	0.999	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.001	0.999	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.001	0.999	0.000
C78.0 Secondary malignant neoplasm of lung	0.000	0.999	0.001
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.999	0.001
T50.5 Appetite depressants	0.000	0.999	0.001
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.999	0.001
T50.1 Loop [high-ceiling] diuretics	0.000	0.999	0.001
T50.0 Mineralocorticoids and their antagonists	0.000	0.999	0.001
M89.39 Hypertrophy of bone (Site unspecified)	0.001	0.999	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.001	0.999	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.001	0.999	0.000
M89.34 Hypertrophy of bone (Hand)	0.001	0.999	0.000
M89.33 Hypertrophy of bone (Forearm)	0.001	0.999	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.001	0.999	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.001	0.999	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.001	0.999	0.000
S92.11 Fracture of talus (open)	0.001	0.999	0.000
E10.1 With ketoacidosis	0.001	0.999	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.999	0.001
E34.9 Endocrine disorder, unspecified	0.000	0.999	0.001
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.001	0.999	0.000
G04.1 Tropical spastic paraplegia	0.001	0.999	0.000
J17.8 Pneumonia in other diseases classified elsewhere	0.001	0.999	0.000
Q27.3 Peripheral arteriovenous malformation	0.000	0.999	0.001
E23 Hypofunction and other disorders of pituitary gland	0.000	0.999	0.001
C70.0 Cerebral meninges	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations